<b>Results:</b> Ceruloplasmin (<i>CP</i>), Solute Carrier Family 25 Member 13 (<i>SLC25A13</i>), and Solute Carrier Family 38 Member 2 (<i>SLC38A2</i>) were selectively dysregulated and associated with poor clinical outcomes in GBM. This evidence concerns the gene SLC38A2 and glioblastoma.